ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,129Medicare Part D Prescriptions Filled, Including Refills

Rank: 94 out of 625

$664K Total Retail Price of All Prescriptions

Rank: 109 out of 625

478 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 478 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 478 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 8,256 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
SIMVASTATIN 648 525 1 2
LEVOTHYROXINE SODIUM 411 334 2 3
AMLODIPINE BESYLATE 396 309 3 1
OMEPRAZOLE 375 303 4 6
HYDROCODONE-ACETAMINOPHEN 374 204 S3 5 4
LISINOPRIL 310 251 6 5
ZOLPIDEM TARTRATE 288 184 7 13
METFORMIN HCL 245 208 8 10
FUROSEMIDE 230 195 9 7
SERTRALINE HCL 223 164 10 26
HYDROCHLOROTHIAZIDE 211 163 11 12
GABAPENTIN 195 140 12 14
POTASSIUM CHLORIDE 193 154 13 19
TRAMADOL HCL 172 136 14 16
CITALOPRAM HBR 169 131 15 24
NEXIUM 168 81 16 21
METOPROLOL TARTRATE 160 122 17 11
PRAVASTATIN SODIUM 158 127 18 8
ATORVASTATIN CALCIUM 141 106 19 9
LOSARTAN POTASSIUM 140 114 20 18
FLUTICASONE PROPIONATE 127 87 21 32
METOPROLOL SUCCINATE 118 109 22 15
CRESTOR 116 97 23 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 112 89 24 27
ALENDRONATE SODIUM 109 86 25 34
CARVEDILOL 97 69 26 23
MELOXICAM 96 75 27 31
ESCITALOPRAM OXALATE 88 65 28 67
AMLODIPINE BESYLATE-BENAZEPRIL 78 50 29 48
TRAZODONE HCL 73 32 30 51
ATENOLOL 73 59 30 22
DIOVAN HCT 72 38 32 52
MIRTAZAPINE 72 44 32 69
NAMENDA 69 69 34 45
TRIAMTERENE-HCTZ 68 47 35 53
MECLIZINE HCL 67 65 36 113
RANITIDINE HCL 65 45 37 25
CYCLOBENZAPRINE HCL 65 42 R 37 65
LOSARTAN-HYDROCHLOROTHIAZIDE 64 64 39 38
SYMBICORT 61 39 40 123
JANUVIA 61 42 40 74
ADVAIR DISKUS 61 47 40 63
PANTOPRAZOLE SODIUM 59 45 43 44
METFORMIN HCL ER 58 32 44 41
CYMBALTA 58 25 44 46
SPIRIVA 56 27 46 70
ISOSORBIDE MONONITRATE ER 54 44 47 49
LYRICA 54 15 47 71
VENLAFAXINE HCL ER 54 48 47 86
PREMARIN 53 43 R 50 105
DONEPEZIL HCL 51 51 51 33
CLOPIDOGREL 50 46 52 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 19, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.